LepVax

Country: Brazil

Location(s): Rio de Janeiro

Hope Rises is currently conducting a safety trial (Phase 1b/2a) to transition the defined subunit vaccine, LepVax, into M. leprae-infected individuals in a leprosy-endemic country.

ILEP Members involved

Hope Rises International
Melissa Edmiston

Partners

MoH, Fiocruz

Physical facilities involved